Position in APUS
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$967,468
-$82,589 QoQ
Shares Held
58,992
0.0% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 41%
None 59%
Common Shares in APUS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $16,666,615,756 across 58 Drug Manufacturers - Specialty & Generic names. APUS ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
47,780,974 | $6,011,802,146 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,176,016 | $2,034,763,795 | |
| 3 | VTRS |
Viatris Inc
|
138,179,864 | $1,720,339,304 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,700,301 | $1,375,793,688 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
48,059,731 | $1,087,591,711 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
20,925,666 | $679,456,373 | |
| 7 | ALKS |
Alkermes plc.
|
18,007,364 | $503,846,043 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
6,699,381 | $445,843,803 |
All Filings in APUS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $967,468 | 58,992 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,050,057 | 58,992 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||